Three poster presentations will be given by the company and its collaborators Florence Atrafi, MD, a clinical investigator on the phase 1 NAPOLY study, has received a prestigious ASCO Merit Award in recognition of her abstract that highlights important research findings Maastricht, The Netherlands, 17 May 2019 – Cristal Therapeutics, a clinical-stage pharmaceutical company developing […]
CRS
July 21–24 CRS Valencia, Spain
GapSummit
June 16-19 GapSummit Boston, USA
BIO2019
June 3-6 BIO2019 Philadelphia, USA
ASCO
May 31 – June 4 ASCO Chicago, USA
CIMT Annual Meeting
May 21-23 CIMT 2019 Annual Meeting Mainz, Germany
Cristal Therapeutics to present data at the American Society of Clinical Oncology (ASCO) 2019 Annual Meeting on lead clinical candidate CPC634 in patients with solid tumors
Three poster presentations will be given by the company and its collaborators Florence Atrafi, MD, a clinical investigator on the phase 1 NAPOLY study, has received a prestigious ASCO Merit Award in recognition of her abstract that highlights important research findings Maastricht, The Netherlands, 17 May 2019 – Cristal Therapeutics, a clinical-stage pharmaceutical company developing […]
Knowledge for Growth
May 9 Knowledge for Growth Ghent, Belgium
China-BIO
May 8-9 China-BIO Shanghai, China
ESMO advanced ovarian cancer
February 22 ESMO advanced ovarian cancer Valencia, Spain
EuroTides
November 6 EuroTides Amsterdam, The Netherlands